149 related articles for article (PubMed ID: 23836213)
1. Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.
Whitman M; Rosen V; Brivanlou AH; Groppe JC; Sebald W; Mueller T
Nat Med; 2013 Jul; 19(7):809-10. PubMed ID: 23836213
[No Abstract] [Full Text] [Related]
2. Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.
Sugimoto H; LeBleu VS; Bosukonda D; Keck P; Taduri G; Bechtel W; Okada H; Carlson W; Bey P; Rusckowski M; Tampe B; Tampe D; Kanasaki K; Zeisberg M; Kalluri R
Nat Med; 2013 Jul; 19(7):810-1. PubMed ID: 23836214
[No Abstract] [Full Text] [Related]
3. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
Sugimoto H; LeBleu VS; Bosukonda D; Keck P; Taduri G; Bechtel W; Okada H; Carlson W; Bey P; Rusckowski M; Tampe B; Tampe D; Kanasaki K; Zeisberg M; Kalluri R
Nat Med; 2012 Feb; 18(3):396-404. PubMed ID: 22306733
[TBL] [Abstract][Full Text] [Related]
4. Bone Morphogenic Protein. Preface.
Litwack G
Vitam Horm; 2015; 99():xiii-xiv. PubMed ID: 26279382
[No Abstract] [Full Text] [Related]
5. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease.
Tobin JF; Celeste AJ
Drug Discov Today; 2006 May; 11(9-10):405-11. PubMed ID: 16635802
[TBL] [Abstract][Full Text] [Related]
7. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
Bosukonda A; Carlson WD
Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
[TBL] [Abstract][Full Text] [Related]
8. Localization of STRO-1, BMP-2/-3/-7, BMP receptors and phosphorylated Smad-1 during the formation of mouse periodontium.
Kémoun P; Laurencin-Dalicieux S; Rue J; Vaysse F; Roméas A; Arzate H; Conte-Auriol F; Farges JC; Salles JP; Brunel G
Tissue Cell; 2007 Aug; 39(4):257-66. PubMed ID: 17662325
[TBL] [Abstract][Full Text] [Related]
9. BMP7: a new bone metastases prevention?
Fournier PG; Guise TA
Am J Pathol; 2007 Sep; 171(3):739-43. PubMed ID: 17690188
[No Abstract] [Full Text] [Related]
10. Deregulated bone morphogenetic protein receptor signaling underlies fibrodysplasia ossificans progressiva.
de Gorter DJ; Jankipersadsing V; Ten Dijke P
Curr Pharm Des; 2012; 18(27):4087-92. PubMed ID: 22630080
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of BMP-Receptor Interaction and Activation.
Mueller TD
Vitam Horm; 2015; 99():1-61. PubMed ID: 26279372
[TBL] [Abstract][Full Text] [Related]
12. Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys.
Bosukonda D; Shih MS; Sampath KT; Vukicevic S
Kidney Int; 2000 Nov; 58(5):1902-11. PubMed ID: 11044210
[TBL] [Abstract][Full Text] [Related]
13. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
[TBL] [Abstract][Full Text] [Related]
14. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
[TBL] [Abstract][Full Text] [Related]
15. Reovirus activates transforming growth factor beta and bone morphogenetic protein signaling pathways in the central nervous system that contribute to neuronal survival following infection.
Beckham JD; Tuttle K; Tyler KL
J Virol; 2009 May; 83(10):5035-45. PubMed ID: 19279118
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells.
Yew KH; Hembree M; Prasadan K; Preuett B; McFall C; Benjes C; Crowley A; Sharp S; Tulachan S; Mehta S; Tei E; Gittes G
J Biol Chem; 2005 Sep; 280(37):32209-17. PubMed ID: 16020542
[TBL] [Abstract][Full Text] [Related]
17. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
[TBL] [Abstract][Full Text] [Related]
18. The Yin and Yang of bone morphogenetic proteins in cancer.
Singh A; Morris RJ
Cytokine Growth Factor Rev; 2010 Aug; 21(4):299-313. PubMed ID: 20688557
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
20. A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton.
Kaplan FS; Glaser DL; Pignolo RJ; Shore EM
Expert Opin Biol Ther; 2007 May; 7(5):705-12. PubMed ID: 17477807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]